ITF Pharma Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • ITF Pharma's estimated annual revenue is currently $13.9M per year.(i)
  • ITF Pharma's estimated revenue per employee is $201,000

Employee Data

  • ITF Pharma has 69 Employees.(i)
  • ITF Pharma grew their employee count by -22% last year.

ITF Pharma's People

NameTitleEmail/Phone
1
VP, Supply Chain ManagementReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
Accounting ManagerReveal Email/Phone
4
Pharmaceutical Sales RepresentativeReveal Email/Phone
5
Specialty Account Manager- Neurology (ultra rare disease)Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$43.2M2156%N/AN/A
#2
$81.8M40710%N/AN/A
#3
$11.7M580%N/AN/A
#4
$1011.8M5034-9%N/AN/A
#5
$44.8M2231%N/AN/A
#6
$13.1M655%N/AN/A
#7
$16.5M8241%N/AN/A
#8
$17.3M86-5%N/AN/A
#9
$67.9M33823%N/AN/A
#10
$14.9M747%N/AN/A
Add Company

What Is ITF Pharma?

At ITF Pharma, we are committed to one primary goal: your health. ITF Pharma is a subsidiary of Italfarmaco S.p.A, a privately held European specialty pharmaceutical company. Italfarmaco is engaged in the development and sale of branded prescription and non-prescription pharmaceutical products in cardiology and thrombosis, oncology/supportive care, CNS, bone metabolism and women?s health. ITF?s main emphasis is on sales and marketing of women?s health, urology and neurology products. We focus our capital, time and energy toward maximizing the potential of our brands. All commercial activity is handled internally and all efforts and resources are directed toward increasing product sales and identifying new product opportunities.

keywords:N/A

N/A

Total Funding

69

Number of Employees

$13.9M

Revenue (est)

-22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ITF Pharma News

2022-04-17 - Marché mondial du traitement de la sclérose latérale ...

... indicateurs clés, prévisions 2028 :Apotex Inc, Ascend Pharmaceuticals LLC, Biogen, Covis Pharma, Ionis Pharmaceutical, ITF Pharma.

2022-04-17 - Amyotrophic Lateral Sclerosis Treatment Market Share, Size ...

Sanofi, Mitsubishi Tanabe Pharma Corporation, BrainStorm Cell Limited, ... Covis Pharma, Apotex Inc., Ascend Laboratories LLC, ITF Pharma,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.9M71-3%N/A
#2
$7.5M7244%N/A
#3
$7.5M7244%N/A
#4
$35M76-5%N/A
#5
$7.5M798%N/A